RAP 0.00% 20.5¢ resapp health limited

Yes, and there's still some work to do.We'll need a double-blind...

  1. 4,928 Posts.
    lightbulb Created with Sketch. 2410
    Yes, and there's still some work to do.

    We'll need a double-blind clinical trial to go ahead. Luckily:
    1. There are lots of test candidates out there both with and without the condition.
    2. The PCR test is a highly accurate gold standard.
    3. PCR test results are (or can be) available in a couple of days so no need for long delays waiting for independent diagnoses.
    4. It's a point-in-time test so there's no longitudinal coverage necessary.

    My guess is all stops out and 12 weeks to have results.

 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.